Anti-Cetuximab Polyclonal Antibody|抗西妥昔单抗多克隆抗体(靶标：西妥昔单抗（抗EGFR单抗）)
- 货号：RB9TAF004014
- 价格：面议
- 点击：189
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA |
| 特异性 | The product is specific for Cetuximab. This antibody serves as an excellent positive control for Cetuximab immunogenicity (ADA) assays. |
| 靶标 | Rabbit polyclonal to Erbitux. |
| 免疫原 | Cetuximab |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 稳定性和储存 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | CAS: 205923-56-4 |
| 背景信息 | Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR. • Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies., PMID:36408164 • Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy., PMID:21255939 |
| 备注 | For research use only. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 倍硫磷单抗 | 6231 |
| 多菌灵/阿苯达唑二合一单抗 | 6270 |
| 三氯噻嗪单抗 | 6374 |
| 吡唑醚菌酯单抗 | 6573 |
| 烯酰吗啉单抗 | 6362 |
| 抑霉唑单抗 | 6118 |
| 恶醚唑（苯醚甲环唑）单抗 | 6304 |
| 赛拉嗪（甲苯噻嗪）单抗 | 6338 |
| 辛硫磷单抗 | 6380 |
| 多效唑单抗 | 6228 |
| 对硫磷单抗 | 6472 |
| 丙溴磷单抗 | 6463 |
| 戊唑醇单抗 | 6453 |
| 莠去津单抗 | 6378 |
| 灭蝇胺单抗 | 6077 |
| 尼卡巴嗪代谢物（DNC）单抗 | 6357 |
| 2.4-二氯苯氧乙酸单抗 | 6221 |
| 甲基对硫磷单抗 | 6310 |
| 左旋咪唑单抗 | 6231 |
| 三唑磷单抗 | 6290 |